Catalyst Wire Dossier Catalyst Wire Dossier

Henatinib

henatinib · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Henatinib, covering 2012-12-21 to 2012-12-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of Henatinib in Patients With Advanced Solid Malignancies [Phase 1]

See pricing